Congratulation! Bioer Technology Received FDA 510(K) Clearance

Hangzhou, China – June 26, 2024 – Bioer Technology, a leading innovator in biotechnology solutions, proudly announces that its Sample Preservative Fluid has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This significant milestone marks a pivotal step in expanding the company's product offerings within the U.S. market.

The FDA 510(k) clearance is a critical endorsement that demonstrates the safety and effectiveness of Bioer's Sample Preservative Fluid for its intended use in preserving biological samples. This preservative fluid is designed to maintain the integrity of nucleic acids, proteins, and other biomolecules in samples, ensuring they remain stable and viable for downstream applications such as diagnostics, research, and clinical testing.

Bioer Technology has long been at the forefront of developing cutting-edge technologies for molecular diagnostics and biological sample preservation. The company's Sample Preservative Fluid is part of a broader portfolio of products designed to meet the evolving needs of the life sciences sector.

With this FDA clearance, Bioer Technology is poised to enhance its presence in the U.S. market, providing advanced sample preservation solutions to laboratories, research institutions, and healthcare facilities across the country. The company plans to continue its efforts in innovation and quality assurance to meet the highest industry standards.